Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 05, 2019 16:15 ET | Source: Zomedica Pharmaceuticals Corp.

Zomedica Announces 2019 Annual Meeting Results

ANN ARBOR, Mich., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, is pleased to...
October 31, 2019 06:55 ET | Source: Zomedica Pharmaceuticals Corp.

Zomedica Commences Final TRUFORMA™ Diagnostic Verification Study

ANN ARBOR, Mich., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, announced today that it has...
September 17, 2019 06:55 ET | Source: Zomedica Pharmaceuticals Corp.

Zomedica names Dr. Stephanie Morley President

ANN ARBOR, Mich., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that Dr....
September 03, 2019 06:55 ET | Source: Zomedica Pharmaceuticals Corp.

Zomedica to Present at RHK Capital 2019 Disruptive Growth Conference, Fall Investor Summit, and Sidoti & Company Fall 2019 Investor Conference

ANN ARBOR, Mich., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it...
August 19, 2019 06:55 ET | Source: Zomedica Pharmaceuticals Corp.

Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors

ANN ARBOR, Mich., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical...
August 08, 2019 16:08 ET | Source: Zomedica Pharmaceuticals Corp.

Zomedica Announces Second Quarter 2019 Financial Results

ANN ARBOR, Mich., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
August 07, 2019 06:55 ET | Source: Zomedica Pharmaceuticals Corp.

Zomedica Announces TRUFORMA™ Assay Updates and R&D Expansion

ANN ARBOR, Mich., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced additional...
June 13, 2019 06:55 ET | Source: Zomedica Pharmaceuticals Corp.

Zomedica Announces Completion of Initial Development of a Lymphoma Assay for its Canine Cancer Liquid Biopsy Platform

ANN ARBOR, Mich., June 13, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it has...
June 12, 2019 16:35 ET | Source: Zomedica Pharmaceuticals Corp.

Zomedica to Present at Raymond James Life Sciences and MedTech Conference

ANN ARBOR, Mich., June 12, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will...
June 10, 2019 06:00 ET | Source: Zomedica Pharmaceuticals Corp.

Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares

ANN ARBOR, Mich., June 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...

Next Page keyboard_arrow_right